We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

103 hedge funds and large institutions have $176M invested in Antares Pharma, Inc. in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 28

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0% more funds holding

Funds holding: 103 → 103 (0)

6% less call options, than puts

Call options by funds: $333K | Put options by funds: $356K

5% less capital invested

Capital invested by funds: $185M → $176M (-$9.32M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
103
Holders Change
–
Holders Change %
0%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
32
Reduced
28
Closed
14
Calls
$333K
Puts
$356K
Net Calls
-$23K
Net Calls Change
-$487K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.99M
2
State Street
State Street
Massachusetts
+$1.88M
3
PAM
Panagora Asset Management
Massachusetts
+$1.24M
4
PCM
Perkins Capital Management
Minnesota
+$1.1M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
-$8.84M
2
BC
Broadfin Capital
New York
-$4.93M
3
AC
Armistice Capital
New York
-$4.63M
4
KCM
Kingdon Capital Management
New York
-$3.05M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$1.08M -$139K -45,135 -12%
RCMNY
27
Rubric Capital Management (New York)
New York
$1.05M -$8.84M -2,864,524 -90%
BAS
28
Brown Advisory Securities
Maryland
$891K – – –
TA
29
Teachers Advisors
New York
$833K – – –
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$740K -$80.9K -26,215 -10%
MCM
31
Moore Capital Management
New York
$648K – – –
Baird Financial Group
32
Baird Financial Group
Wisconsin
$613K -$18.5K -6,000 -3%
GCP
33
GSA Capital Partners
United Kingdom
$590K -$62K -20,085 -10%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$487K +$10.4K +3,363 +2%
AQR Capital Management
35
AQR Capital Management
Connecticut
$477K +$454K +147,094 New
Barclays
36
Barclays
United Kingdom
$442K +$326K +105,644 +344%
RJFSA
37
Raymond James Financial Services Advisors
Florida
$434K +$119K +38,475 +40%
M&T Bank
38
M&T Bank
New York
$421K – – –
CIBC Private Wealth Group
39
CIBC Private Wealth Group
Georgia
$405K – – –
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$394K – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$389K -$5.34K -1,730 -1%
Citadel Advisors
42
Citadel Advisors
Florida
$372K -$49.5K -16,044 -12%
TDC
43
Thompson Davis & Co
Virginia
$365K -$247K -79,966 -41%
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$335K -$1.41K -458 -0.4%
BP
45
Ballentine Partners
Massachusetts
$324K – – –
PNC Financial Services Group
46
PNC Financial Services Group
Pennsylvania
$324K – – –
V
47
Veritable
Delaware
$324K – – –
Millennium Management
48
Millennium Management
New York
$315K -$916K -296,879 -75%
AIG
49
American International Group
New York
$312K +$22.2K +7,203 +8%
CS
50
Credit Suisse
Switzerland
$305K +$196K +63,597 +209%
1
2
3 4 5

ATRS Hedge Fund Activity: Q3 2017 in Review

103 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q3 2017, worth a combined $176M — down 5% from $185M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ATRS positions and 14 closed out — a net gain of 1 holder — while 32 added to existing stakes and 28 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $8.99M. The largest seller was Rubric Capital Management (New York), cutting an estimated $8.84M.

  • 103 institutional investors held Antares Pharma, Inc. (ATRS) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $176M of Antares Pharma, Inc. stock for Q3 2017, down 5% quarter-over-quarter.
  • 15 funds opened new Antares Pharma, Inc. positions in Q3 2017 and 14 closed out, a net change of +1 holder.
  • The largest Antares Pharma, Inc. buyer in Q3 2017 was Fidelity Investments, an estimated $8.99M added.
  • The largest Antares Pharma, Inc. seller in Q3 2017 was Rubric Capital Management (New York), an estimated $8.84M sold.

Based on aggregated 13F filings for Q3 2017.